Alphatec (NASDAQ:ATEC) is scheduled to be announcing its earnings results after the market closes on Thursday, November 8th. Analysts expect the company to announce earnings of ($0.13) per share for the quarter.
NASDAQ ATEC opened at $3.05 on Wednesday. The company has a quick ratio of 1.67, a current ratio of 2.47 and a debt-to-equity ratio of 1.11. Alphatec has a 12-month low of $2.31 and a 12-month high of $4.21. The stock has a market cap of $134.40 million, a price-to-earnings ratio of -8.47 and a beta of 1.35.
Several analysts have issued reports on ATEC shares. Zacks Investment Research upgraded shares of Alphatec from a “strong sell” rating to a “hold” rating in a research report on Wednesday, October 3rd. HC Wainwright restated a “buy” rating and set a $4.00 price target on shares of Alphatec in a research report on Friday, August 3rd.
Alphatec Holdings, Inc, a medical technology company, focuses on the design, development, and promotion of products for the surgical treatment of spine disorders. Its product portfolio and pipeline address the cervical, thoracolumbar, and intervertebral regions of the spine; and cover various spinal disorders and surgical procedures.
Read More: Index Funds
Receive News & Ratings for Alphatec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec and related companies with MarketBeat.com's FREE daily email newsletter.